HomeNVYTF • OTCMKTS
add
Novacyt SA
Nakaraang pagsara
$0.54
Sakop ng taon
$0.54 - $1.25
Market cap
31.78M EUR
Average na Volume
3.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | — | — |
Net na kita | — | — |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 30.46M | -30.87% |
Kabuuang asset | 70.63M | -47.22% |
Kabuuang sagutin | 22.75M | -51.15% |
Kabuuang equity | 47.88M | — |
Natitirang share | 70.78M | — |
Presyo para makapag-book | 0.79 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | — | — |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Itinatag
Hul 3, 2006
Website
Mga Empleyado
240
